美股市場個股詳情
AQST Aquestive Therapeutics
- 4.510
- -0.225-4.75%
收盤價 11/21 16:00 (美東)
- 4.504
- -0.006-0.14%
盤後 20:01 (美東)
4.11億總市值-9933市盈率TTM
4.690最高價4.440最低價126.43萬股成交量4.690今開4.735昨收577.02萬成交額1.58%換手率虧損市盈率(靜)9117.82萬總股本6.23052周最高-9.06市淨率3.61億流通值1.84052周最低--股息TTM8010.19萬流通股20.696歷史最高--股息率TTM5.28%振幅0.618歷史最低4.563平均價1股每手
關於Aquestive Therapeutics公司
aququestive Therapeutics, Inc.從事識別、開發和商業化差異化產品，以解決未滿足的醫療需求並解決患者的治療問題。其產品線包括Libervant、AQST-108、AQST-305、Suboxone和Zuplenz。
公司介紹
公司代碼AQST
公司名稱Aquestive Therapeutics
上市日期2018/07/25
發行價格15.00
成立日期2004
CEOMr. Daniel Barber
所屬市場納斯達克
員工數量135
年結日12-31
公司地址30 Technology Drive
城市Warren
省份新澤西
國家美國
郵編07059
電話1-908-941-1900
董事高管
- 姓名
- 職務
- 年薪
- Daniel Barber
- Chief Executive Officer, President and Director
- 249.61萬
- Dr. Carl N. Kraus, M.D.
- Chief Medical Officer
- --
- Lori J. Braender
- Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- 119.40萬
- Cassie Jung
- Chief Operating Officer
- --
- A. Mark Schobel
- Chief Innovation and Technology Officer
- --
- A. Ernest Toth, Jr
- Chief Financial Officer
- 111.59萬
- Stephen Wargacki
- Chief Science Officer
- --
- Peter Boyd
- Senior Vice President, Information Technology, Human Resources and Communications
- --
- Dr. Gregory B. Brown,M.D.
- Chairman of the Board
- 15.08萬
- John S. Cochran
- Vice Chairman of the Board
- 13.72萬
- Dr. Julie Krop, M.D.
- Independent Director
- 13.77萬
- Dr. Marco Taglietti,M.D.
- Independent Director
- 12.18萬
- Timothy E. Morris
- Independent Director
- 14.52萬
- Abigail L. Jenkins, B.A.,M.S.
- Independent Director
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據